Atrial Fibrillation Trial, Recruiting NCT06061120 Sponsor: RWTH Aachen University Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06061120
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are scheduled to have an ablation procedure for a heart rhythm condition known as supraventricular tachycardia (this includes atrial fibrillation, typical atrial flutter, AV nodal reentry tachycardia, or an accessory pathway condition)
  • People who are 18 years of age or older (confirm with trial site)

Who may not be able to join:

  • People whose health is currently unstable and who need intensive medical care
  • People who have difficulty with language or limited thinking and memory abilities that would make detailed medical questioning and informed consent not possible
  • People with certain other heart rhythm problems occurring at the same time, specifically extra heartbeats making up more than 5% of heartbeats per day (this applies to the questionnaire part of the study)
  • People who have previously had an ablation procedure at the same location in the heart for atrial fibrillation (this applies to the ECG monitoring part of the study)
  • People with extra heartbeats making up more than 5% of heartbeats per day (this applies to the ECG monitoring part of the study)
  • People who have an implanted electrical device such as a pacemaker, defibrillator, or deep brain stimulator (this applies to the ECG monitoring part of the study)
  • People with a known allergy to the adhesive electrodes used for ECG monitoring (this applies to the ECG monitoring part of the study)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Matthias D Zink, MD, RWTH Aachen University

Phone: 00492418035113

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
RWTH Aachen University
Registry
ClinicalTrials.gov
Start date
1 September 2021
Est. completion
30 September 2024

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Triggers of supraventricular arrhythmia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov